Provided by Tiger Trade Technology Pte. Ltd.

First Trust Innovation Leaders ETF

40.35
+0.44001.10%
Post-market: 40.350.00000.00%19:30 EDT
Volume:25.10K
Turnover:1.01M
Market Cap:369.20M
PE:- -
High:40.38
Open:40.21
Low:39.99
Close:39.91
52wk High:41.10
52wk Low:28.19
Shares:9.15M
Float Shares:9.15M
Volume Ratio:0.51
T/O Rate:0.27%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Global Markets-Tech Stocks Boosted by Micron but Treasury Rout Hangs over Markets

Reuters
·
Oct 01

Nontraditional Players Enter CPU Market Amid Surging Demand

Dow Jones
·
Oct 01

Why Did Google Stock Gain in After-Hours Trading on Wednesday?

TIPRANKS
·
Oct 01

PRESS Digest-Wall Street Journal - October 1

Reuters
·
Oct 01

Yang Delong: Watch US Stocks During National Day Holiday, Expect Post-Holiday Market "Opening Bell" Rally

Deep News
·
Oct 01

After Testing Muse, I Sold Off My Entire Airbnb Position

Deep News
·
Oct 01

Gemini 4 Launches to Fanfare but Internal Staff Question Its Real-World Performance

Deep News
·
Oct 01

Press Release: Incubeta Completes Acquisition of XPON's Specialist GMP and GCP Division

Dow Jones
·
Oct 01

24H | Nu Holdings Jumps 6%; Rocket Lab, Constellation Energy Advance 3%; Alphabet Rises 2%

US Overnight
·
Oct 01

The Next Frontier for Obesity Drugs Isn't How Much Weight You Lose, but What Kind

Dow Jones
·
Oct 01

Constellation Stock Rises as Amazon Backs Nuclear Plant Expansion

Dow Jones
·
Oct 01

Market Chatter: Alphabet's Google Staff Question Gemini 4 Performance Despite Strong Benchmarks

MT Newswires Live
·
Oct 01

Google Announces Gemini 4 Flagship AI Model After Months of Delays

Reuters
·
Oct 01

Primer: NVIDIA Corp (NVDA US) - Oct 2026

Smartkarma
·
Oct 01

Eli Lilly Says Foundayo Drug Helped Patients Lose Weight in Phase 3 Trial

Dow Jones
·
Oct 01

Tech CEOs Privately Questioned Amodei for Sounding AI Alarm Bells

Dow Jones
·
Oct 01

Analysts Are Bullish on These NA Stocks: Moleculin Biotech (MBRX), Alphabet Class A (GOOGL)

TIPRANKS
·
Oct 01

Eli Lilly’s Foundayo shows cardiovascular safety in type 2 diabetes study

TIPRANKS
·
Oct 01

Lilly's Oral Glp-1, Foundayo (Orforglipron), Demonstrated Cardiovascular Safety Alongside Sustained A1c Reduction and Weight Loss in Its Largest and Longest Type 2 Diabetes Study

THOMSON REUTERS
·
Oct 01

Eli Lilly - Achieve-4: Foundayo Shows 16% Lower Mace-4 and 23% Lower Mace-3 Risk vs Insulin Glargine

THOMSON REUTERS
·
Oct 01